4//SEC Filing
Zheng Yongxiang 4
Accession 0001437749-24-018797
CIK 0001389545other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 9:17 PM ET
Size
5.3 KB
Accession
0001437749-24-018797
Insider Transaction Report
Form 4
Zheng Yongxiang
Director
Transactions
- Award
Restricted Stock Units
2024-05-28+30,000→ 30,000 total→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. The number of restricted stock units and related contingent right to receive common stock does not give effect to the 1-for-35 reverse stock split the issuer effected on May 30, 2024.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001910375
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 9:17 PM ET
- Size
- 5.3 KB